Organogenesis (ORGO) was upgraded by
Weiss Ratings from "sell (d+)" to "hold (c)".
Organogenesis (ORGO) had its price target lowered by BTIG Research from $9.00 to $8.00. They now have a "buy" rating on the stock.
Organogenesis Holdings Inc (ORGO) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ... [Yahoo! Finance]
Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue